1ab2: THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE SRC HOMOLOGY 2 DOMAIN OF C-ABL
1abo: CRYSTAL STRUCTURE OF THE COMPLEX OF THE ABL TYROSINE KINASE SH3 DOMAIN WITH 3BP-1 SYNTHETIC PEPTIDE
1abq: CRYSTAL STRUCTURE OF THE UNLIGANDED ABL TYROSINE KINASE SH3 DOMAIN
1awo: THE SOLUTION NMR STRUCTURE OF ABL SH3 AND ITS RELATIONSHIP TO SH2 IN THE SH(32) CONSTRUCT, 20 STRUCTURES
1bbz: CRYSTAL STRUCTURE OF THE ABL-SH3 DOMAIN COMPLEXED WITH A DESIGNED HIGH-AFFINITY PEPTIDE LIGAND: IMPLICATIONS FOR SH3-LIGAND INTERACTIONS
1fpu: CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
1iep: CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.
1ju5: Ternary complex of an Crk SH2 domain, Crk-derived phophopeptide, and Abl SH3 domain by NMR spectroscopy
1m52: Crystal Structure of the c-Abl Kinase domain in complex with PD173955
1opj: Structural basis for the auto-inhibition of c-Abl tyrosine kinase
1opk: Structural basis for the auto-inhibition of c-Abl tyrosine kinase
1opl: Structural basis for the auto-inhibition of c-Abl tyrosine kinase
1zzp: Solution structure of the F-actin binding domain of Bcr-Abl/c-Abl
2abl: SH3-SH2 DOMAIN FRAGMENT OF HUMAN BCR-ABL TYROSINE KINASE
2e2b: Crystal structure of the c-Abl kinase domain in complex with INNO-406
2f4j: Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinase Inhibitor VX-680
2fo0: Organization of the SH3-SH2 Unit in Active and Inactive Forms of the c-Abl Tyrosine Kinase
2g1t: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
2g2f: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
2g2h: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
2g2i: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
2gqg: X-ray Crystal Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain
2hiw: Crystal Structure of Inactive Conformation Abl Kinase Catalytic Domain Complexed with Type II Inhibitor
2hyy: Human Abl kinase domain in complex with imatinib (STI571, Glivec)
2hz0: Abl kinase domain in complex with NVP-AEG082
2hz4: Abl kinase domain unligated and in complex with tetrahydrostaurosporine
2hzi: Abl kinase domain in complex with PD180970
2hzn: Abl kinase domain in complex with NVP-AFG210
2o88: Crystal structure of the N114A mutant of ABL-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions
1ab2: THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE SRC HOMOLOGY 2 DOMAIN OF C-ABL
1abo: CRYSTAL STRUCTURE OF THE COMPLEX OF THE ABL TYROSINE KINASE SH3 DOMAIN WITH 3BP-1 SYNTHETIC PEPTIDE
1abq: CRYSTAL STRUCTURE OF THE UNLIGANDED ABL TYROSINE KINASE SH3 DOMAIN
1awo: THE SOLUTION NMR STRUCTURE OF ABL SH3 AND ITS RELATIONSHIP TO SH2 IN THE SH(32) CONSTRUCT, 20 STRUCTURES
1bbz: CRYSTAL STRUCTURE OF THE ABL-SH3 DOMAIN COMPLEXED WITH A DESIGNED HIGH-AFFINITY PEPTIDE LIGAND: IMPLICATIONS FOR SH3-LIGAND INTERACTIONS
1fpu: CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
1iep: CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.
1ju5: Ternary complex of an Crk SH2 domain, Crk-derived phophopeptide, and Abl SH3 domain by NMR spectroscopy
1m52: Crystal Structure of the c-Abl Kinase domain in complex with PD173955
1opj: Structural basis for the auto-inhibition of c-Abl tyrosine kinase
1opk: Structural basis for the auto-inhibition of c-Abl tyrosine kinase
1opl: Structural basis for the auto-inhibition of c-Abl tyrosine kinase
1zzp: Solution structure of the F-actin binding domain of Bcr-Abl/c-Abl
2abl: SH3-SH2 DOMAIN FRAGMENT OF HUMAN BCR-ABL TYROSINE KINASE
2e2b: Crystal structure of the c-Abl kinase domain in complex with INNO-406
2f4j: Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinase Inhibitor VX-680
2fo0: Organization of the SH3-SH2 Unit in Active and Inactive Forms of the c-Abl Tyrosine Kinase
2g1t: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
2g2f: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
2g2h: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
2g2i: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
2gqg: X-ray Crystal Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain
2hiw: Crystal Structure of Inactive Conformation Abl Kinase Catalytic Domain Complexed with Type II Inhibitor
2hyy: Human Abl kinase domain in complex with imatinib (STI571, Glivec)
2hz0: Abl kinase domain in complex with NVP-AEG082
2hz4: Abl kinase domain unligated and in complex with tetrahydrostaurosporine
2hzi: Abl kinase domain in complex with PD180970
2hzn: Abl kinase domain in complex with NVP-AFG210
2o88: Crystal structure of the N114A mutant of ABL-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions
